AU5493500A - Antibody-based treatment for streptococcus pneumoniae infection - Google Patents

Antibody-based treatment for streptococcus pneumoniae infection

Info

Publication number
AU5493500A
AU5493500A AU54935/00A AU5493500A AU5493500A AU 5493500 A AU5493500 A AU 5493500A AU 54935/00 A AU54935/00 A AU 54935/00A AU 5493500 A AU5493500 A AU 5493500A AU 5493500 A AU5493500 A AU 5493500A
Authority
AU
Australia
Prior art keywords
antibody
streptococcus pneumoniae
based treatment
pneumoniae infection
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54935/00A
Inventor
David Briles
Gary S. Nabors
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
UAB Research Foundation
Original Assignee
Aventis Pasteur SA
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA, UAB Research Foundation filed Critical Aventis Pasteur SA
Publication of AU5493500A publication Critical patent/AU5493500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU54935/00A 1999-06-16 2000-06-16 Antibody-based treatment for streptococcus pneumoniae infection Abandoned AU5493500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13952499P 1999-06-16 1999-06-16
US60/139524 1999-06-16
PCT/US2000/016581 WO2000076587A1 (en) 1999-06-16 2000-06-16 Antibody-based treatment for streptococcus pneumoniae infection

Publications (1)

Publication Number Publication Date
AU5493500A true AU5493500A (en) 2001-01-02

Family

ID=22487078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54935/00A Abandoned AU5493500A (en) 1999-06-16 2000-06-16 Antibody-based treatment for streptococcus pneumoniae infection

Country Status (5)

Country Link
EP (1) EP1194187A1 (en)
JP (1) JP2003525208A (en)
AU (1) AU5493500A (en)
CA (1) CA2377431A1 (en)
WO (1) WO2000076587A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0306782D0 (en) * 2003-03-25 2003-04-30 Neutec Pharma Plc Treatment of infection due to clostridium difficile
US9938326B2 (en) 2012-09-19 2018-04-10 Osaka University Pneumococcal vaccine containing pneumococcal surface protein A

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679768A (en) * 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
CA2304128A1 (en) * 1997-09-18 1999-03-25 Robert Becker Improved method of production of pneumococcal surface proteins

Also Published As

Publication number Publication date
CA2377431A1 (en) 2000-12-21
WO2000076587A1 (en) 2000-12-21
JP2003525208A (en) 2003-08-26
EP1194187A1 (en) 2002-04-10

Similar Documents

Publication Publication Date Title
HK1043728A1 (en) Vaccine against streptococcus pneumoniae
ZA200202306B (en) Topical treatment of streptococcal infections.
GB0107658D0 (en) Streptococcus pneumoniae
AU5043500A (en) Antibacterial compounds
AU2064401A (en) Enhanced channel estimation
AU2002351623A1 (en) Streptococcus antigens
AU2002218462A1 (en) Thermal treatment system
AU2480499A (en) Calcification-resistant medical articles
AU2001253265A1 (en) Oral treatment systems
AU6908500A (en) Treatment for narcolepsy
AU2001255300A1 (en) Multi-channel-bandwidth frequency-hopping system
MX264033B (en) Enzyme treatment for infection.
AU2001280598A1 (en) Anti-occlusion catheter
AU2733200A (en) Dna mobility modifier
AU2001239961A1 (en) Catheter rapid exchange device
AU2000277330A1 (en) Catheter system
AU5547000A (en) Novel treatment
AU2001253568A1 (en) Lipopolysaccharide-conjugate vaccine for sepsis treatment
AU6892900A (en) Antibacterial amidinomethyl- and guanidinomethyl-oxazolidinones
AU7730100A (en) Endoscope system
DE60023158D1 (en) Phagenresistentes streptococcus thermophilus
AU5493500A (en) Antibody-based treatment for streptococcus pneumoniae infection
AU1194201A (en) Fluorotellurite, amplifier glasses
AU4665100A (en) Novel disaccharide antibacterial agents
ZA200108013B (en) Monthly closes for treatment of Streptococcus pneumoniae infections.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase